Flecainide toxicity late after liver transplantation

Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, mal...

Full description

Saved in:
Bibliographic Details
Published inProceedings - Baylor University. Medical Center Vol. 34; no. 3; pp. 378 - 379
Main Authors Elsaid, Ossama, Tecson, Kristen M., Khan, Hafiza, Assar, Manish D.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis Ltd 22.01.2021
Taylor & Francis
Subjects
Cardiac arrhythmia
Case Report
Case Studies
Liver transplants
Toxicity
Antiarrhythmic
flecainide
supraventricular tachycardia
Online AccessGet full text
ISSN0899-8280
1525-3252
DOI10.1080/08998280.2020.1871266

Cover

More Information
Summary:Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
The authors report no conflicts of interest. The patient’s husband granted permission to publish this case report.
ISSN:0899-8280
1525-3252
DOI:10.1080/08998280.2020.1871266